Artigos de revistas sobre o tema "Soluble CD89"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Soluble CD89".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Launay, Pierre, Béatrice Grossetête, Michelle Arcos-Fajardo, Emmanuelle Gaudin, Sonia P. Torres, Lucie Beaudoin, Natacha Patey-Mariaud de Serre, Agnès Lehuen e Renato C. Monteiro. "Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)". Journal of Experimental Medicine 191, n.º 11 (6 de junho de 1999): 1999–2010. http://dx.doi.org/10.1084/jem.191.11.1999.
Texto completo da fontevan Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha e Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89". Journal of Immunology 163, n.º 11 (1 de dezembro de 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Texto completo da fonteEsteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey e Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy". International Journal of Molecular Sciences 21, n.º 4 (18 de fevereiro de 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Texto completo da fonteWu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang e Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History". Disease Markers 2020 (16 de janeiro de 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Texto completo da fonteCambier, Alexandra, Patrick J. Gleeson, Lilia Abbad, Fanny Canesi, Jennifer da Silva, Julie Bex-Coudrat, Georges Deschênes et al. "Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy". Kidney International 101, n.º 2 (fevereiro de 2022): 274–87. http://dx.doi.org/10.1016/j.kint.2021.09.023.
Texto completo da fonteBerthelot, Laureline, Thomas Robert, Vincent Vuiblet, Thierry Tabary, Antoine Braconnier, Moustapha Dramé, Olivier Toupance, Philippe Rieu, Renato C. Monteiro e Fatouma Touré. "Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes". Kidney International 88, n.º 4 (outubro de 2015): 815–22. http://dx.doi.org/10.1038/ki.2015.158.
Texto completo da fonteVuong, Mai T., Mirjana Hahn-Zoric, Sigrid Lundberg, Iva Gunnarsson, Cees van Kooten, Lars Wramner, Maria Seddighzadeh et al. "Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy". Kidney International 78, n.º 12 (dezembro de 2010): 1281–87. http://dx.doi.org/10.1038/ki.2010.314.
Texto completo da fonteHahn-Zoric, Mirjana, Mai Vuong, Sigrid Lundberg, Lars Wramner, Jarl Ahlmen, Lars Å. Hanson, Iva Gunnarsson, Stefan Jacobson e Leonid Padyukov. "Su.82. Evidence for Genetic Regulation of Fc Alpha Receptor (CD89) Expression: Study of Soluble CD89 in Plasma of IgA Nephropathy Patients and Healthy Controls". Clinical Immunology 127 (janeiro de 2008): S151. http://dx.doi.org/10.1016/j.clim.2008.03.433.
Texto completo da fonteHahn-Zoric, Mirjana, Neda Tahmasebifar, Cees van Kooten, Jarl Ahlmen, Svante Swerkersson, Sverker Hansson, Ulla Berg, Lars Åke Hanson, Leonid Padyukov e Stefan H. Jacobson. "Immunoassays for Detection of Soluble Fc Alpha Receptor (CD89) in Plasma of IgA Nephropathy Patients". Clinical Immunology 123 (2007): S54—S55. http://dx.doi.org/10.1016/j.clim.2007.03.335.
Texto completo da fonteBerthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors". Journal of Experimental Medicine 209, n.º 4 (26 de março de 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Texto completo da fonteNockher, W. A., e J. E. Scherberich. "Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro." Journal of Immunology 158, n.º 3 (1 de fevereiro de 1997): 1345–52. http://dx.doi.org/10.4049/jimmunol.158.3.1345.
Texto completo da fonteBerthelot, L., P. Housset, V. Sauvaget, A. Jamin, R. C. Monteiro e E. Pillebout. "Complexes IgA-CD89 soluble comme biomarqueurs d’atteinte rénale et facteur de risque de progression au cours du purpura rhumatoïde". Néphrologie & Thérapeutique 9, n.º 5 (setembro de 2013): 278. http://dx.doi.org/10.1016/j.nephro.2013.07.184.
Texto completo da fonteTissandié, Emilie, Willy Morelle, Laureline Berthelot, François Vrtovsnik, Eric Daugas, Francine Walker, Didier Lebrec et al. "Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89–IgA and IgG–IgA complexes: common mechanisms for distinct diseases". Kidney International 80, n.º 12 (dezembro de 2011): 1352–63. http://dx.doi.org/10.1038/ki.2011.276.
Texto completo da fonteMonteiro, Renato C., Dina Rafeh e Patrick J. Gleeson. "Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?" Microorganisms 10, n.º 4 (22 de março de 2022): 683. http://dx.doi.org/10.3390/microorganisms10040683.
Texto completo da fonteChai, Jian-Guo, Silvia Vendetti, Istvan Bartok, Diana Schoendorf, Katalin Takacs, James Elliott, Robert Lechler e Julian Dyson. "Critical Role of Costimulation in the Activation of Naive Antigen-Specific TCR Transgenic CD8+ T Cells In Vitro". Journal of Immunology 163, n.º 3 (1 de agosto de 1999): 1298–305. http://dx.doi.org/10.4049/jimmunol.163.3.1298.
Texto completo da fonteLal, R. B., D. L. Rudolph, C. S. Dezzutti, P. S. Linsley e H. E. Prince. "Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands." Journal of Immunology 157, n.º 3 (1 de agosto de 1996): 1288–96. http://dx.doi.org/10.4049/jimmunol.157.3.1288.
Texto completo da fonteMotta, Juliana, Morgana Castelo-Branco e Vivian Rumjanek. "Characterization of human monocyte-derived dendritic cells in the presence of leukemic cell soluble products (127.14)". Journal of Immunology 188, n.º 1_Supplement (1 de maio de 2012): 127.14. http://dx.doi.org/10.4049/jimmunol.188.supp.127.14.
Texto completo da fonteChai, Jian-Guo, Istvan Bartok, Diane Scott, Julian Dyson e Robert Lechler. "T:T Antigen Presentation by Activated Murine CD8+ T Cells Induces Anergy and Apoptosis". Journal of Immunology 160, n.º 8 (15 de abril de 1998): 3655–65. http://dx.doi.org/10.4049/jimmunol.160.8.3655.
Texto completo da fonteChung, Yeonseok, Jae-Hoon Chang, Mi-Na Kweon, Paul D. Rennert e Chang-Yuil Kang. "CD8α–11b+ dendritic cells but not CD8α+ dendritic cells mediate cross-tolerance toward intestinal antigens". Blood 106, n.º 1 (1 de julho de 2005): 201–6. http://dx.doi.org/10.1182/blood-2004-11-4240.
Texto completo da fonteHock, B. D., J. L. O'Donnell, K. Taylor, A. Steinkasserer, J. L. McKenzie, A. G. Rothwell e K. L. Summers. "Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients". Tissue Antigens 67, n.º 1 (janeiro de 2006): 57–60. http://dx.doi.org/10.1111/j.1399-0039.2005.00524.x.
Texto completo da fonteMorva, Ahsen, Sébastien Lemoine, Achouak Achour, Jacques-Olivier Pers, Pierre Youinou e Christophe Jamin. "Maturation and function of human dendritic cells are regulated by B lymphocytes". Blood 119, n.º 1 (5 de janeiro de 2012): 106–14. http://dx.doi.org/10.1182/blood-2011-06-360768.
Texto completo da fonteLi, Haiyan, Sungyoul Hong, Jianfei Qian, Yuhuan Zheng, Jing Yang e Qing Yi. "Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells". Blood 116, n.º 2 (15 de julho de 2010): 210–17. http://dx.doi.org/10.1182/blood-2009-11-255026.
Texto completo da fonteOehler, Leopold, Otto Majdic, Winfried F. Pickl, Johannes Stöckl, Elisabeth Riedl, Johannes Drach, Klemens Rappersberger, Klaus Geissler e Walter Knapp. "Neutrophil Granulocyte–committed Cells Can Be Driven to Acquire Dendritic Cell Characteristics". Journal of Experimental Medicine 187, n.º 7 (6 de abril de 1998): 1019–28. http://dx.doi.org/10.1084/jem.187.7.1019.
Texto completo da fonteTekguc, Murat, James Badger Wing, Motonao Osaki, Jia Long e Shimon Sakaguchi. "Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells". Proceedings of the National Academy of Sciences 118, n.º 30 (23 de julho de 2021): e2023739118. http://dx.doi.org/10.1073/pnas.2023739118.
Texto completo da fonteArcaro, Alexandre, Claude Grégoire, Talitha R. Bakker, Lucia Baldi, Martin Jordan, Laurence Goffin, Nicole Boucheron et al. "CD8β Endows CD8 with Efficient Coreceptor Function by Coupling T Cell Receptor/CD3 to Raft-associated CD8/p56lck Complexes". Journal of Experimental Medicine 194, n.º 10 (19 de novembro de 2001): 1485–95. http://dx.doi.org/10.1084/jem.194.10.1485.
Texto completo da fonteTsuji, Shoutaro, Misako Matsumoto, Osamu Takeuchi, Shizuo Akira, Ichiro Azuma, Akira Hayashi, Kumao Toyoshima e Tsukasa Seya. "Maturation of Human Dendritic Cells by Cell Wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: Involvement of Toll-Like Receptors". Infection and Immunity 68, n.º 12 (1 de dezembro de 2000): 6883–90. http://dx.doi.org/10.1128/iai.68.12.6883-6890.2000.
Texto completo da fonteLechmann, Matthias, Daniëlle J. E. B. Krooshoop, Diana Dudziak, Elisabeth Kremmer, Christine Kuhnt, Carl G. Figdor, Gerold Schuler e Alexander Steinkasserer. "The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells". Journal of Experimental Medicine 194, n.º 12 (17 de dezembro de 2001): 1813–21. http://dx.doi.org/10.1084/jem.194.12.1813.
Texto completo da fonteNauta, Alma J., Ellie Lurvink, Alwine B. Kruisselbrink, Roelof Willemze e Willem E. Fibbe. "Mesenchymal Stem Cells Inhibit Generation and Function of Both Monocyte-Derived and CD34-Derived Dendritic Cells." Blood 106, n.º 11 (16 de novembro de 2005): 593. http://dx.doi.org/10.1182/blood.v106.11.593.593.
Texto completo da fonteCorinti, Silvia, Donata Medaglini, Andrea Cavani, Maria Rescigno, Gianni Pozzi, Paola Ricciardi-Castagnoli e Giampiero Girolomoni. "Human Dendritic Cells Very Efficiently Present a Heterologous Antigen Expressed on the Surface of Recombinant Gram-Positive Bacteria to CD4+ T Lymphocytes". Journal of Immunology 163, n.º 6 (15 de setembro de 1999): 3029–36. http://dx.doi.org/10.4049/jimmunol.163.6.3029.
Texto completo da fonteFaries, Mark B., Isabelle Bedrosian, Shuwen Xu, Gary Koski, James G. Roros, Mirielle A. Moise, Hung Q. Nguyen, Friederike H. C. Engels, Peter A. Cohen e Brian J. Czerniecki. "Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development". Blood 98, n.º 8 (15 de outubro de 2001): 2489–97. http://dx.doi.org/10.1182/blood.v98.8.2489.
Texto completo da fonteAndersson, Anders, Apostolos Bossios, Carina Malmhäll, Margareta Sjöstrand, Maria Eldh, Britt-Marie Eldh, Pernilla Glader et al. "Effects of tobacco smoke on IL-16 in CD8+ cells from human airways and blood: a key role for oxygen free radicals?" American Journal of Physiology-Lung Cellular and Molecular Physiology 300, n.º 1 (janeiro de 2011): L43—L55. http://dx.doi.org/10.1152/ajplung.00387.2009.
Texto completo da fonteZinser, Elisabeth, Matthias Lechmann, Antje Golka, Manfred B. Lutz e Alexander Steinkasserer. "Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83". Journal of Experimental Medicine 200, n.º 3 (2 de agosto de 2004): 345–51. http://dx.doi.org/10.1084/jem.20030973.
Texto completo da fonteBowman, Christine E., Ada Chen, Damie Juat, Kaustubh Parashar, Julie Clor, Hema Singh, Ritu Kushwaha et al. "Abstract 321: Inhibition of CD39 results in elevated ATP and activation of myeloid cells to promote anti-tumor immunity". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 321. http://dx.doi.org/10.1158/1538-7445.am2022-321.
Texto completo da fonteTomita, Yuji, Eri Watanabe, Masumi Shimizu, Yasuyuki Negishi, Yukihiro Kondo e Hidemi Takahashi. "Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells". Cancer Immunology, Immunotherapy 68, n.º 10 (17 de setembro de 2019): 1605–19. http://dx.doi.org/10.1007/s00262-019-02396-8.
Texto completo da fonteSimone, Rita, Giampaola Pesce, Princey Antola, Margarita Rumbullaku, Marcello Bagnasco, Nicola Bizzaro e Daniele Saverino. "The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses". BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/215763.
Texto completo da fonteButler, Marcus O., Osamu Imataki, Yoshihiro Yamashita, Makito Tanaka, Sascha Ansén, Alla Berezovskaya, Matthew I. Milstein et al. "Human CD4+ T Cells Help CD8+ T Cells Proliferate Ex Vivo by Secreting Both IL-2/IL-21 and Upregulating IL-21R". Blood 116, n.º 21 (19 de novembro de 2010): 4284. http://dx.doi.org/10.1182/blood.v116.21.4284.4284.
Texto completo da fontePrazma, Charlene M., e Thomas F. Tedder. "Ag-engaged B cells express CD83, a sensitive marker for B cell activation (83.15)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S114. http://dx.doi.org/10.4049/jimmunol.178.supp.83.15.
Texto completo da fontePaul, Santanu, Charles C. Chu, Brian A. McCarthy, Erin Boyle, Bettie M. Steinberg, Matthew Kaufman, Jonathan Kolitz, Steven L. Allen, Kanti R. Rai e Nicholas Chiorazzi. "Activation of Nucleic Acid-Sensing Toll-Like Receptors Induces Proliferation, Cytokine Production, Immunogenic Phenotype, and Plasma Cell Differentiation of CLL Cells and Immunoglobulin Production." Blood 110, n.º 11 (16 de novembro de 2007): 1137. http://dx.doi.org/10.1182/blood.v110.11.1137.1137.
Texto completo da fonteBjørge, Line, Tone Skeie Jensen, Christian A. Vedeler, Elling Ulvestad, Einar K. Kristoffersen e Roald Matre. "Soluble CD59 in pregnancy and infancy". Immunology Letters 36, n.º 2 (maio de 1993): 233. http://dx.doi.org/10.1016/0165-2478(93)90058-a.
Texto completo da fontePaszkiet, Brian, Andrew Worden, Yajin Ni, Saran Bao, Franck Lemiale, Boro Dropulic e Laurent Humeau. "CD86 and CD54 Co-Expression on VSV-G Pseudotyped HIV-1 Based Vectors Improves Transduction and Activation of Human Primary CD4+ T Lymphocytes." Blood 104, n.º 11 (16 de novembro de 2004): 1754. http://dx.doi.org/10.1182/blood.v104.11.1754.1754.
Texto completo da fonteZelek, Wioleta, Loek Willems, Ricardo Brandwijk, Sam Loveless, Neil R. Robertson e B. Paul Morgan. "High levels of soluble CD59 in CSF compared to plasma suggests intrathecal source of soluble CD59". Molecular Immunology 89 (setembro de 2017): 186. http://dx.doi.org/10.1016/j.molimm.2017.06.179.
Texto completo da fonteZhu, Lv-yun, Li Nie, Tong Shao, Wei-ren Dong, Li-xin Xiang e Jian-zhong Shao. "B cells in primitive vertebrate act as pivotal antigen presenting cells in priming adaptive immunity (P5035)". Journal of Immunology 190, n.º 1_Supplement (1 de maio de 2013): 110.18. http://dx.doi.org/10.4049/jimmunol.190.supp.110.18.
Texto completo da fonteStachel, Daniel K., Uta Eickelmann, Rita Meilbeck, Michael H. Albert, Raymund Buhmann, Michael Hallek e Irene Schmid. "Coculture of Pediatric Acute Lymphoblastic Leukemia (ALL) Blasts with CD40 Ligand Transfected Cells Leads to Changes of Surface Antigens and RNA Expression." Blood 106, n.º 11 (16 de novembro de 2005): 856. http://dx.doi.org/10.1182/blood.v106.11.856.856.
Texto completo da fontevan der Merwe, P. Anton, Dale L. Bodian, Susan Daenke, Peter Linsley e Simon J. Davis. "CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics". Journal of Experimental Medicine 185, n.º 3 (3 de fevereiro de 1997): 393–404. http://dx.doi.org/10.1084/jem.185.3.393.
Texto completo da fonteTomkinson, B. E., M. C. Brown, S. H. Ip, S. Carrabis e J. L. Sullivan. "Soluble CD8 during T cell activation." Journal of Immunology 142, n.º 7 (1 de abril de 1989): 2230–36. http://dx.doi.org/10.4049/jimmunol.142.7.2230.
Texto completo da fonteZelek, Wioleta M., Lewis M. Watkins, Owain W. Howell, Rhian Evans, Sam Loveless, Neil P. Robertson, Marijke Beenes, Loek Willems, Ricardo Brandwijk e B. Paul Morgan. "Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59". Multiple Sclerosis Journal 25, n.º 4 (9 de fevereiro de 2018): 523–31. http://dx.doi.org/10.1177/1352458518758927.
Texto completo da fonteNair, Jayakumar R., Louise M. Carlson, Cheryl Rozanski, Lawrence H. Boise, Asher Chanan-Khan e Kelvin P. Lee. "Direct interaction with dendritic cells through CD28-CD80/CD86 supports plasma cell survival (34.9)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 34.9. http://dx.doi.org/10.4049/jimmunol.182.supp.34.9.
Texto completo da fonteWong, C. K., L. C. W. Lit, L. S. Tam, E. K. Li e C. W. K. Lam. "Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus". Rheumatology 44, n.º 8 (3 de maio de 2005): 989–94. http://dx.doi.org/10.1093/rheumatology/keh663.
Texto completo da fonteButler, Marcus O., Sascha Ansén, Makito Tanaka, Osamu Imataki, Alla Berezovskaya, Mary M. Mooney, Genita Metzler, Matthew I. Milstein, Lee M. Nadler e Naoto Hirano. "A Series of Human Cell-Based Artificial APC Expands Long-Lived, Th1-Biased, Viral Antigen-Specific CD4+ T Cells with a Central/Effector Memory Phenotpype Restricted by Common HLA-DR Alleles". Blood 116, n.º 21 (19 de novembro de 2010): 354. http://dx.doi.org/10.1182/blood.v116.21.354.354.
Texto completo da fonteEckhardt, J., S. Kreiser, M. Döbbeler, C. Nicolette, M. A. DeBenedette, I. Y. Tcherepanova, C. Ostalecki et al. "Soluble CD83 ameliorates experimental colitis in mice". Mucosal Immunology 7, n.º 4 (15 de janeiro de 2014): 1006–18. http://dx.doi.org/10.1038/mi.2013.119.
Texto completo da fonte